What the patent dataset reveals about the materials frontier

A dataset of 78 patents and academic papers spanning 2005 to 2023 maps the intersection of sustainable materials science and functional biomedical applications. While the corpus centres on printed electronics and functional ink formulations, four interconnected themes emerge with direct relevance to biodegradable orthopedic implant material development: sustainable and bio-based substrates, environmentally friendly manufacturing processes, functional material formulations that prioritise reduced environmental and physiological burden, and end-of-life material separation strategies.

The dominant patent assignees across this dataset include Vorbeck Materials Corporation — which holds an extensive portfolio of graphene-based printed electronics patents — Guangzhou Chinaray Optoelectronic Materials Ltd., and various government research organisations developing sustainable electronic materials. Their collective innovations in sustainable materials science provide foundational processing approaches now being studied and adapted for the orthopedic biomaterials sector, as tracked by organisations such as WIPO through its global patent monitoring programmes.

Bio-based substrates and the case for sustainable formulations

Cellulose, lignin, and shellac-paper composites are the bio-based substrate candidates with the most documented functional potential. Research published in 2020 demonstrated that forest-derived materials can serve as functional precursors: a laser-induced graphitisation process applied to a forest-based ink achieved low sheet resistance, opening possibilities for producing sustainable functional materials entirely from renewable resources.

Paper-based substrates have emerged as particularly promising. A 2022 study on shellac-paper composites documented that paper offers biodegradability, recyclability, and low cost while remaining compatible with roll-to-roll manufacturing processes. Critically, the researchers emphasised that “truly sustainable” systems must support the separation of functional materials from substrates at end of life — a principle that translates directly into the design requirements for biodegradable orthopedic implants, where controlled degradation and biocompatibility are equally paramount. Standards bodies including ISO have increasingly formalised such end-of-life design criteria in biomedical materials guidance.

“To produce sustainable formulations, it is necessary to ensure that most of the materials used in the formulation are biobased, biodegradable, or not considered critical raw materials.”

A comprehensive 2023 review on sustainable inks for printed electronics articulated the definitive framework: to produce sustainable formulations, “it is necessary to ensure that most of the materials used in the formulation are biobased, biodegradable, or not considered critical raw materials.” This requirement aligns precisely with the demands of biodegradable orthopedic implant development, where both physiological burden and supply-chain resilience drive material selection. Ethyl cellulose — a cellulose derivative with an established biocompatibility profile — has already appeared in patent formulations from DST Innovations Limited, signalling the bridging of these two domains.

Additive manufacturing: fewer steps, less waste, better implant geometries

Additive manufacturing approaches offer a measurable environmental and operational advantage over conventional subtractive fabrication. Research published in 2020 on sustainable advanced manufacturing of printed electronics quantified the benefit: printing technologies “significantly reduce not only the number of manufacturing steps, but also the need for energy, time, consumables, as well as the waste.” For orthopedic implant manufacturing, this matters both at scale and at the individual patient level, where bespoke geometries are increasingly clinically desirable.

The breadth of compatible deposition methods documented in the patent record is substantial. Vorbeck Materials Corporation’s 2016 printed electronics patent enumerates over 14 distinct approaches: inkjet printing, spin coating, thermal transfer methods, screen printing, rotary screen printing, gravure printing, capillary printing, offset printing, electrohydrodynamic printing, flexographic printing, pad printing, stamping, xerography, and microcontact printing. Each method carries different resolution, throughput, and substrate-compatibility trade-offs relevant to implant fabrication contexts.

High-resolution fabrication capabilities are advancing at the micro and nano scale. A 2023 review of electrohydrodynamic (EHD) jet printing described the technique as offering “unparalleled benefits” for microstructure fabrication, with potential applications spanning wearable electronics to smart packaging — technology domains that share demanding material requirements with implantable biomedical devices. EHD jet printing’s ability to deposit materials at sub-micron precision is directly relevant to the surface engineering of degradable implant scaffolds.

Water-based and non-toxic formulations for biocompatible processing

Water-based formulations represent one of the most clinically transferable advances in functional materials science. A 2019 study demonstrated stable water-based functional inks produced from electrochemically exfoliated graphene at concentrations of approximately 2.25 mg/mL, achieving stability exceeding one month. Aqueous processing is a prerequisite for biocompatible material development: organic solvents introduce residual toxicity risks that are unacceptable in implant-grade applications regulated by bodies such as the U.S. FDA.

Beyond water as a solvent, the selection of non-toxic organic solvents is advancing the sustainability of functional material processing. A 2018 study on sustainable production of highly conductive multilayer graphene ink employed Dihydrolevoglucosenone (Cyrene) — a non-toxic, bio-derived solvent — to significantly speed up and reduce the cost of material processing. Transitioning to green solvents in implant material processing could reduce both manufacturing-site hazards and residual toxicity concerns in finished implants, a consideration increasingly embedded in lifecycle assessment frameworks promoted by OECD.

The formulation science documented in patents from Guangzhou Chinaray Optoelectronic Materials Ltd. describes functional material thin films processed via inkjet printing, nozzle printing, typographic printing, screen printing, dip coating, and spin coating — each depositing functional materials from inorganic ester solvents. While designed for optoelectronic applications, these multi-method formulation platforms demonstrate the flexibility of functional material systems that could be adapted for implant-grade substrate coating and surface modification.

Key patent holders and emerging innovation trends

Vorbeck Materials Corporation leads patent activity in the functional materials space most adjacent to biodegradable orthopedic implant applications. Its filings — spanning from a 2013 patent on electrically conductive inks comprising functionalized graphene sheets and at least one binder, to a 2016 patent covering over 14 distinct printing methods — demonstrate both the breadth of manufacturing compatibility and the depth of graphene-based materials IP this organisation holds.

Guangzhou Chinaray Optoelectronic Materials Ltd.

Guangzhou Chinaray Optoelectronic Materials Ltd. has established significant intellectual property in functional material formulations, with patents in both 2018 and 2023 covering organic functional materials for printed applications. Their formulation frameworks, describing functional materials in inorganic ester solvents and processed through multiple deposition methods, represent adaptable platforms with potential relevance to implant coating and substrate functionalisation.

Government research organisations

Government research bodies have contributed meaningfully to printable materials IP. Her Majesty the Queen in Right of Canada filed a 2019 patent describing silver carboxylate and copper formate-based flake-less printable compositions — formulation approaches that reduce particle agglomeration challenges in functional inks. DST Innovations Limited’s 2016 patent describes formulations using ethyl cellulose — a cellulose derivative with established biocompatibility profiles directly relevant to implant applications.

Literature trend: the sustainability imperative

The literature trend across the full 2005–2023 dataset shows increasing focus on environmental sustainability as a primary design criterion, not an afterthought. A 2021 comprehensive review systematically addressed the environmental footprint of functional material manufacturing across fabrication methods, inks, substrates, applications, and environmental impacts. This shift in the research framing — from performance-first to performance-and-sustainability — mirrors the trajectory of orthopedic biomaterials research as tracked by journals indexed by institutions such as NIH‘s National Library of Medicine, where biocompatibility and degradation kinetics are now standard evaluation criteria alongside mechanical properties.

“Electrohydrodynamic jet printing offers unparalleled benefits for microstructure fabrication” — a precision applicable to the surface engineering of degradable implant scaffolds at sub-micron resolution.